通貨 / ABEO
ABEO: Abeona Therapeutics Inc
5.74
USD
0.00
(0.00%)
ABEOの今日の為替レートは、0.00%変化しました。日中、通貨は1あたり5.65の安値と5.82の高値で取引されました。
Abeona Therapeutics Incダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ABEO News
- Investing Abeona therapeutics closes sale of priority review voucher for $155 million
- Investing Beacon Therapeutics licenses Abeona’s AAV204 capsid for retinal therapies
- Investing Abeona Therapeutics ® added to Membership of U.S. Small-cap Russell 2000 ® Index and Broad-market Russell 3000 ® Index
- Investing Abeona Therapeutics ® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
- Seeking Alpha Abeona Therapeutics' Zevaskyn Vs. Krystal Biotech's Vyjuvek (KRYS, ABEO)
- Seeking Alpha Capricor: A Hold Rating With Regulatory FDA Form Given For Deramiocel Advancement (CAPR)
- Seeking Alpha Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (ABEO)
- Investing Abeona Therapeutics at Jefferies Conference: ZivaSkin’s Promising Launch
- Investing Oppenheimer assumes coverage on Abeona Therapeutics stock
- Investing Abeona Therapeutics ® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Investing Abeona Therapeutics ® to Present at the Jefferies Global Healthcare Conference
- Benzinga PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Abeona Therapeutics (NASDAQ:ABEO), Ascentage Pharma Group (NASDAQ:AAPG)
- Investing Stifel cuts Abeona Therapeutics price target to $20, maintains Buy
- Investing Earnings call transcript: Abeona Therapeutics beats EPS forecast in Q1 2025
- Investing Abeona Therapeutics ® Reports First Quarter 2025 Financial Results and Corporate Updates
- Benzinga Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease - Abeona Therapeutics (NASDAQ:ABEO)
- Benzinga Abeona Stock Surges to 52-Week High: What's Behind The Move? - Abeona Therapeutics (NASDAQ:ABEO)
- Benzinga Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy - Abeona Therapeutics (NASDAQ:ABEO)
- Seeking Alpha Undercovered Dozen: 3D Systems, Seritage, Topicus, Timken +
- Seeking Alpha Abeona: pz-cel Has Massive Potential For RDEB Patients (NASDAQ:ABEO)
- Seeking Alpha Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Upside (ABEO)
- Seeking Alpha Abeona Stock: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher
- Seeking Alpha Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS)
- Seeking Alpha Abeona Therapeutics Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:ABEO)